2021
DOI: 10.1016/j.biologicals.2021.01.005
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of adjuvant activity of Astragaloside VII and its combination with different immunostimulating agents in Newcastle Disease vaccine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 36 publications
0
8
0
Order By: Relevance
“…In addition, a combination of adjuvants usually yield better immune responses than either adjuvant component alone; reduce dose of individual adjuvant component and frequency of immunizations; and may induce humoral immune response and cellular immune response ( 19 ). It was proven that the involvement of AST in oil adjuvant production was beneficial in improving the immune response ( 20 ).Therefore, AST were used as an immunopotentiator to improve the efficacy of a single dose of PRV inactivated vaccine in this study.…”
Section: Discussionmentioning
confidence: 92%
“…In addition, a combination of adjuvants usually yield better immune responses than either adjuvant component alone; reduce dose of individual adjuvant component and frequency of immunizations; and may induce humoral immune response and cellular immune response ( 19 ). It was proven that the involvement of AST in oil adjuvant production was beneficial in improving the immune response ( 20 ).Therefore, AST were used as an immunopotentiator to improve the efficacy of a single dose of PRV inactivated vaccine in this study.…”
Section: Discussionmentioning
confidence: 92%
“…Promoting the maturation and activation of APCs such as macrophages or dendritic cells [34,35]; Enhancing the levels of antigen-specific antibodies enhances the body's immune defense against antigens [35][36][37];…”
Section: Macrophyllosaponin B (12)mentioning
confidence: 99%
“…Based on the promising immunostimulant effect comparable to commercialized adjuvants Alum and Quillaja saponins (including QS-21) 1 , 2 , 3 , our team has been prompted to carry out advance studies for developing Astragaloside VII (AST VII) ( Fig. 1 ) as a new vaccine adjuvant or an immunotherapeutic agent.…”
Section: Acknowledgmentmentioning
confidence: 99%